IL87643A - Thiazoles, their preparation and pharmaceutical preparations containing them - Google Patents

Thiazoles, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL87643A
IL87643A IL8764388A IL8764388A IL87643A IL 87643 A IL87643 A IL 87643A IL 8764388 A IL8764388 A IL 8764388A IL 8764388 A IL8764388 A IL 8764388A IL 87643 A IL87643 A IL 87643A
Authority
IL
Israel
Prior art keywords
thiadiazol
methyl
tetrahydropyridine
azabicyclo
alkyl
Prior art date
Application number
IL8764388A
Other languages
English (en)
Hebrew (he)
Other versions
IL87643A0 (en
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27449981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL87643(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878721342A external-priority patent/GB8721342D0/en
Priority claimed from GB888801758A external-priority patent/GB8801758D0/en
Priority claimed from GB888812145A external-priority patent/GB8812145D0/en
Priority claimed from GB888817311A external-priority patent/GB8817311D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of IL87643A0 publication Critical patent/IL87643A0/xx
Publication of IL87643A publication Critical patent/IL87643A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL8764388A 1987-09-10 1988-09-01 Thiazoles, their preparation and pharmaceutical preparations containing them IL87643A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878721342A GB8721342D0 (en) 1987-09-10 1987-09-10 Therapeutic agents
GB888801758A GB8801758D0 (en) 1988-01-27 1988-01-27 Therapeutic agents
GB888812145A GB8812145D0 (en) 1988-05-23 1988-05-23 Therapeutic agents
GB888817311A GB8817311D0 (en) 1988-07-20 1988-07-20 Therapeutic agents

Publications (2)

Publication Number Publication Date
IL87643A0 IL87643A0 (en) 1989-02-28
IL87643A true IL87643A (en) 1994-05-30

Family

ID=27449981

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8764388A IL87643A (en) 1987-09-10 1988-09-01 Thiazoles, their preparation and pharmaceutical preparations containing them

Country Status (10)

Country Link
EP (1) EP0307142B1 (ko)
JP (1) JPH01104070A (ko)
KR (1) KR890005103A (ko)
AT (1) ATE111464T1 (ko)
AU (1) AU626209B2 (ko)
DE (1) DE3851498T2 (ko)
DK (1) DK503188A (ko)
IL (1) IL87643A (ko)
NZ (1) NZ225999A (ko)
PT (1) PT88422B (ko)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224237A (en) * 1987-04-15 1991-04-26 Beecham Group Plc Bicyclic compounds (n bridged compounds)
CA2000041A1 (en) * 1988-10-13 1990-04-13 Barry S. Orlek Compounds
GB8830226D0 (en) * 1988-12-23 1989-02-22 Beecham Group Plc Novel compounds
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5106853A (en) * 1989-05-15 1992-04-21 Merck Sharp & Dohme, Ltd. Oxadiazole and its salts, their use in treating dementia
EP0413545B1 (en) * 1989-08-16 1997-05-14 Beecham Group Plc Azabicyclic compounds
DE69026197T2 (de) * 1989-10-07 1997-01-09 Beecham Group Plc Azabizyklische Verbindungen, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0459568A3 (en) * 1990-05-31 1992-09-30 Merck Sharp & Dohme Ltd. Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5124460A (en) * 1991-05-06 1992-06-23 Merck Sharp & Dohme Ltd. Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
GB9127279D0 (en) * 1991-12-23 1992-02-19 Ici Plc Heterocyclic derivatives
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
AU3901393A (en) * 1992-04-10 1993-11-18 Zeneca Limited Biphenylylquinuclidine derivatives as squalene synthase inhibitors
SE9201478D0 (sv) * 1992-05-11 1992-05-11 Kabi Pharmacia Ab Heteroaromatic quinuclidinenes, their use and preparation
GB9211796D0 (en) * 1992-06-04 1992-07-15 Ici Plc Heterocyclic derivatives
GB9216721D0 (en) * 1992-08-06 1992-09-23 Ici Plc Therapeutic heterocyclic derivatives
GB9218334D0 (en) * 1992-08-28 1992-10-14 Ici Plc Heterocyclic compounds
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
WO1994014803A1 (en) * 1992-12-21 1994-07-07 Zeneca Limited Quinuclidine derivatives as squalene synthase inhibitors
NZ271311A (en) * 1993-08-19 1999-09-29 Novo Nordisk As Pharmaceutical usage of oxa- or thia-diazole-substituted pyridines
US6265419B1 (en) 1993-12-21 2001-07-24 Novo Nordisk A/S Method of treating gastrointestinal motility disorders
US6271229B1 (en) 1993-08-19 2001-08-07 Novo Nordisk A/S Method of treating gastrointestinal motility disorders
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
US5545638A (en) * 1993-12-21 1996-08-13 Novo Nordisk A/S Method of treating gastrointestinal motility disorders
IL112024A (en) * 1993-12-21 1999-07-14 Novo Nordisk As Pharmaceutical compositions comprising tetrahydropyridine derivatives substituted with oxadiazole or thiadiazole for treating gastrointestinal motility disorders
US5821370A (en) * 1994-10-24 1998-10-13 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5565475A (en) * 1994-11-08 1996-10-15 Muhlhauser; Mark A. Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
US5612351A (en) * 1994-11-08 1997-03-18 Novo Nordisk A/S Method of treating urinary bladder dysfunctions
US5510478A (en) * 1994-11-30 1996-04-23 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
US5859004A (en) * 1995-02-17 1999-01-12 Novo Nordisk A/S Use of heterocyclic compounds for the treatment of conditions caused by malfunctioning of the nicotinic cholinergic system
GB9510459D0 (en) 1995-05-24 1995-07-19 Zeneca Ltd Bicyclic amines
US5712270A (en) * 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
JP2000501097A (ja) * 1995-11-29 2000-02-02 イーライ・リリー・アンド・カンパニー ヘテロ環式化合物およびそれらの使用
US5889019A (en) * 1995-11-29 1999-03-30 Eli Lilly And Company Heterocyclic compounds and their use
IL124419A0 (en) * 1995-12-07 1998-12-06 Lilly Co Eli Composition for treating pain
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
ATE250055T1 (de) * 1996-04-24 2003-10-15 Novo Nordisk As Heterozyklische verbindungen, ihre herstellung und ihre anwendung
CA2251851A1 (en) * 1996-05-13 1997-11-20 Roger Salmon Bicyclic amines as insecticides
EP0821954A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating mental retardation
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
EP0821956A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating disruptive behavior disorders
US5834458A (en) * 1996-10-09 1998-11-10 Eli Lilly And Company Heterocyclic compounds and their use
GB9623944D0 (en) * 1996-11-15 1997-01-08 Zeneca Ltd Bicyclic amine derivatives
GB9624114D0 (en) * 1996-11-20 1997-01-08 Zeneca Ltd Pesticidal bicyclic amine derivatives
JP2001506989A (ja) 1996-11-26 2001-05-29 ゼネカ リミテッド ８−アザビシクロ［３．２．１］オクタン−、８−アザビシクロ［３．２．１］オクト−６−エン−、９−アザビシクロ［３．３．１］ノナン−、９−アザ−３−オキサビシクロ［３．３．１］ノナン−、および９−アザ−３−チアビシクロ［３．３．１］ノナン誘導体、それらの調整および殺虫剤としてのそれらの使用
GB9624611D0 (en) 1996-11-26 1997-01-15 Zeneca Ltd Bicyclic amine compounds
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
EP2013204B1 (en) 2006-03-24 2015-02-18 Array Biopharma, Inc. 2-aminopyridine analogs as glucokinase activators
MX2009008323A (es) * 2007-02-15 2009-08-13 Argenta Discovery Ltd Derivados heterociclicos como receptores muscarinicos m3.
JP2008270387A (ja) * 2007-04-18 2008-11-06 Matsushita Electric Ind Co Ltd プリント配線板
EP2072506A1 (de) * 2007-12-21 2009-06-24 Bayer CropScience AG Thiazolyloxyphenylamidine oder Thiadiazolyloxyphenylamidine und deren Verwendung als Fungizide
US20110294835A1 (en) 2008-05-15 2011-12-01 The Board Of Trustees Of The University Of Illinois Muscarinic Agonists as Cognitive Enhancers
US9549928B2 (en) 2011-04-29 2017-01-24 The University Of Toledo Muscarinic agonists as enhancers of cognitive flexibility

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3770749A (en) * 1971-07-01 1973-11-06 Monsanto Co 3-pyridyl-1,2,4-thiadiazole-5-carboxamides
BE789441A (fr) * 1971-09-30 1973-03-29 Ciba Geigy Nouvel herbicide selectif et procede pour sa preparation
US4226609A (en) * 1979-03-01 1980-10-07 Olin Corporation Selected 3-trichloromethyl-5-cyclic amine-1,2,4-thiadiazole compounds and their use as ammonium nitrification inhibitors
DE3060330D1 (en) * 1979-04-06 1982-06-09 Bayer Ag Azolyloxy-acetamides, process for their preparation and their use as herbicides
US4282144A (en) * 1979-06-01 1981-08-04 Eastman Kodak Company Azo dyes derived from 5-membered heterocyclic amines and aromatic amine couplers containing sulfo groups, or salts thereof
US4301069A (en) * 1980-06-13 1981-11-17 Eastman Kodak Company Azo dyes from five membered ring heterocyclic amines and aniline, tetrahydroquinoline and benzomorpholine couplers containing thiosulfate alkyl groups
DE3038636A1 (de) * 1980-10-13 1982-05-27 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von substituierten oxyessigsaeureamiden
DE3422861A1 (de) * 1984-06-20 1986-01-02 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von heteroaryloxyacetamiden
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
DE3789039T2 (de) * 1986-06-27 1994-06-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen.
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
JP3353406B2 (ja) * 1993-08-16 2002-12-03 富士電機株式会社 燃料電池発電装置

Also Published As

Publication number Publication date
PT88422B (pt) 1992-10-30
DE3851498T2 (de) 1995-05-04
DK503188D0 (da) 1988-09-09
IL87643A0 (en) 1989-02-28
ATE111464T1 (de) 1994-09-15
NZ225999A (en) 1992-04-28
AU2207388A (en) 1989-03-16
KR890005103A (ko) 1989-05-11
AU626209B2 (en) 1992-07-23
EP0307142B1 (en) 1994-09-14
DE3851498D1 (de) 1994-10-20
PT88422A (pt) 1989-07-31
DK503188A (da) 1989-05-01
EP0307142A1 (en) 1989-03-15
JPH01104070A (ja) 1989-04-21

Similar Documents

Publication Publication Date Title
IL87643A (en) Thiazoles, their preparation and pharmaceutical preparations containing them
EP0239309B1 (en) Oxadiazoles useful in the treatment of senile dementia
US5242927A (en) Prodrugs for oxadiazole muscarinic agonists
US5260293A (en) Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia
US5405853A (en) Thiadiazoles useful in the treatment of senile dementia
EP0307140B1 (en) Oxadiazolyl-azabicycloheptanes for the treatment of senile dementia
NZ227684A (en) Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions
EP0402056A2 (en) Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
AU628311B2 (en) Lipophilic (3,5) substituted oxadiazole derivatives
EP0307141A2 (en) Oxazoles and thiazoles for the treatment of senile dementia
JP2022550640A (ja) Ｋｖ１．３カリウムシェーカーチャネル遮断薬としてのアリール複素環式化合物
EP0366304A2 (en) Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them
US5324724A (en) Compounds for the treatment of senile dementia
CN113950477B (zh) 颗粒体蛋白前体调节剂和其使用方法
US5324723A (en) Oxazoles and thiazoles for the treatment of senile dementia
US20230023559A1 (en) Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
EP0350118A2 (en) Spiro-azabicyclic muscarinic agonists
EP0412797A2 (en) The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes
TW202310831A (zh) 作為Kv1.3鉀SHAKER離子通道阻斷劑之螺吲哚啉酮化合物
CA2022887A1 (en) Therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees